常用名 | Trigriluzole | CAS号 | 1926203-09-9 |
---|---|---|---|
价格 | 纯度 | 99.0% | |
备货期 | 10天 | 库存 | 现货 |
产品详情(用途,包装等)
用途: Trigriluzole (BHV-4157) is a novel glutamate modulator for the treatment of mild-to-moderate Alzheimer’s disease (AD); Trigriluzole is a third-generation prodrug and new chemical entity that modulates glutamate, the most abundant excitatory neurotransmitter in the human body. Trigriluzole has a wide range of pharmacological actions, including interactions with several types of ion channels, cellular signaling mechanisms and facilitation of glutamate reuptake. Some potential targets related to trigriluzole’s mechanism of action include (1) reducing presynaptic glutamate release through actions at the voltage-gated ion channels, (2) facilitating glutamate uptake via EAATs located on glial cells, (3) enhancing transmission through synaptic AMPA receptors, (4) altering GABAergic neurotransmission, and (5) effecting neurotrophic agents such as BDNF. Anxiety Phase 3 Clinical 物理化学性质: CAS号:1926203-09-9 常用中文名:Trigriluzole 常用英文名:Troriluzole 分子式:C15H16F3N5O4S 分子量:419.379 密度:1.5±0.1 g/cm3 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:2-8°C |